Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir

BACKGROUND: In this study, we aimed to compare the intensive care unit (ICU) admission rate of hospitalized mild/moderate COVID-19 patients treated with hydroxychloroquine (HCQ), favipiravir, and HCQ plus favipiravir. METHODS: Single center retrospective designed observational study conducted in Ank...

Descripción completa

Detalles Bibliográficos
Autores principales: Guner, Rahmet, Hasanoglu, Imran, Kayaaslan, Bircan, Aypak, Adalet, Akinci, Esragul, Bodur, Hurrem, Eser, Fatma, Kaya Kalem, Ayse, Kucuksahin, Orhan, Ates, Ihsan, Bastug, Aliye, Tezer Tekce, Yasemin, Bilgic, Zeynep, Gursoy, Fahriye Melis, Akca, Hatice Nisa, Izdes, Seval, Erdem, Deniz, Asfuroglu, Emra, Hezer, Habibe, Kilic, Hatice, Cıvak, Musa, Aydogan, Sibel, Buzgan, Turan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771901/
https://www.ncbi.nlm.nih.gov/pubmed/33647553
http://dx.doi.org/10.1016/j.jiph.2020.12.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771901/
https://www.ncbi.nlm.nih.gov/pubmed/33647553
http://dx.doi.org/10.1016/j.jiph.2020.12.017

Ejemplares similares